~58 spots leftby May 2026

Physical Therapy for Infant Motor Delay

Recruiting at 2 trial locations
SP
SA
SA
SP
EH
Overseen ByElizabeth Hoffman, DPT
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Shirley Ryan AbilityLab
Must not be taking: Anticoagulants
Disqualifiers: Open wounds, Immune deficiencies, Limb defects, others
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

Study Aims Pilot study: Due to the large recruitment goal and length of the project, the study team/PIs will evaluate the first cohort of 6-10 participants to refine study procedures and study-related materials. If no major modifications are made to the protocol as a result of this evaluation, data from these participants will be included for analysis. Aim 1: Evaluate the efficacy of an early, evidence-based, clinical experience-based therapeutic intervention (from the NICU to 12-months corrected age) on improving motor function and reducing severity of motor delays in infants at 12-months corrected age. The investigators hypothesize that the intervention group will demonstrate an average 8-point difference (0.5 standard deviation) compared to the standard of care group. \[an 8-point difference is considered a clinically meaningful difference\] Aim 2: Evaluate the early effects (i.e., before 12 months) of a therapeutic intervention, provided from NICU to 12-months corrected age, on motor function and severity of motor delay. The Investigators hypothesize that a statistically significant higher percentage of infants in the intervention group will demonstrate improved motor function and reduced severity of motor delays, compared to the standard of care group-assessed using sensors, the NSMDA and TIMP-as early as 3-months corrected age. Aim 3: Evaluate whether an early intervention that focuses on caregiver engagement improves caregiver well-being. The invetigators hypothesize that an intervention that focuses on supporting and addressing the individual needs of the caregiver will improve caregiver well-being. The investigators will evaluate these effects using the PedsQL (Family Impact Module).

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications. It is best to discuss this with the study team or your doctor.

What data supports the effectiveness of the treatment Physical Therapy for Infant Motor Delay?

Research shows that structured neonatal physical therapy can improve neurobehavior and general movements in moderate to late preterm infants, suggesting potential benefits for infants with motor delays.12345

Is physical therapy safe for infants?

Research on physical therapy for infants, including those at high risk for developmental issues, shows no significant safety concerns. Studies have not reported harmful effects, suggesting it is generally safe for infants.13567

How does physical therapy differ from other treatments for infant motor delay?

Physical therapy for infant motor delay is unique because it involves hands-on techniques and exercises to improve motor skills, rather than using medications or surgical interventions. It focuses on enhancing movement and coordination through structured activities, which can be administered by therapists or parents, making it a non-invasive and interactive approach.12368

Research Team

Arun Jayaraman, PT, PhD

Arun Jayaraman, PT, PhD

Principal Investigator

Shirley Ryan AbilityLab

Eligibility Criteria

This trial is for infants in the NICU at risk of motor delays due to conditions like low birth weight, brain injuries, or bronchopulmonary dysplasia. They must be stable and able to start therapy between 34-48 weeks postmenstrual age. Infants with severe health issues, open wounds, bleeding disorders, or under DCFS custody are excluded.

Inclusion Criteria

My baby was admitted to the NICU and qualifies for special follow-up care.
I have a disorder affecting my brain, such as injury or developmental issue.
My baby needed breathing support at 36 weeks after conception and was born before 32 weeks.
See 2 more

Exclusion Criteria

Followed primarily in another clinic (including meningomyelocele and related conditions/trisomy 21)
Any other condition that would preclude participation in the study, as determined by the PI
Previously enrolled in competing randomized trial with developmental outcome variables
See 8 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Infants receive a physical therapy intervention from NICU to 12-months corrected age, with up to two therapist visits per week in addition to standard care.

Up to 12 months
Up to 2 visits per week (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 12-months corrected age and optional assessments at 18 and 24-months corrected age.

12 months with optional extensions
Assessments at 12, 18, and 24 months corrected age

Optional Extension

Optional assessments and caregiver surveys at 18 and 24-months corrected age to monitor long-term outcomes.

Up to 24 months

Treatment Details

Interventions

  • Physical Therapy intervention (Behavioural Intervention)
Trial OverviewThe study tests a physical therapy intervention from the NICU until the infant reaches 12 months corrected age. It aims to improve motor function and reduce severity of delays compared to standard care. The impact on caregiver well-being is also assessed.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Physical Therapy InterventionExperimental Treatment1 Intervention
Infants enrolled in this arm will receive the intervention in addition to standard of care
Group II: Standard of CareActive Control1 Intervention
Infants enrolled in this arm will receive standard of care

Find a Clinic Near You

Who Is Running the Clinical Trial?

Shirley Ryan AbilityLab

Lead Sponsor

Trials
212
Recruited
17,900+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+

University of Illinois at Chicago

Collaborator

Trials
653
Recruited
1,574,000+

Northwestern Medicine

Collaborator

Trials
14
Recruited
9,500+

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborator

Trials
275
Recruited
5,182,000+

Findings from Research

A study involving 134 high-risk infants showed that early physical therapy did not lead to significant improvements in neurologic status, motor development, or physical growth compared to conventional care at 12 months.
Infants born weighing less than 750 g consistently experienced significant delays in growth and development, regardless of whether they received early physical therapy or not, indicating that very low birth weight is a critical factor in developmental outcomes.
Early physical therapy effects on the high-risk infant: a randomized controlled trial.Piper, MC., Kunos, VI., Willis, DM., et al.[2007]
A study involving 153 preterm infants showed that parent-administered physical therapy significantly improved motor performance by 37 weeks' postmenstrual age compared to usual care, with a notable effect size of 0.40.
The intervention, which included activities promoting postural control and head control, was conducted for just 10 minutes twice a day over 3 weeks, suggesting that even brief, targeted physical therapy can have beneficial effects on motor development in medically stable preterm infants.
Early Parent-Administered Physical Therapy for Preterm Infants: A Randomized Controlled Trial.Ustad, T., Evensen, KA., Campbell, SK., et al.[2018]
A structured neonatal physical therapy program (SNP) significantly improved neurobehavior and general movements in moderate to late preterm infants, as shown by assessments conducted on 60 infants in a clinical trial.
Infants receiving the SNP showed better scores in motor development and a decrease in poor repertoire general movements compared to those receiving usual care, suggesting that this therapy can enhance developmental outcomes in this vulnerable population.
Neonatal PT Improves Neurobehavior and General Movements in Moderate to Late Preterm Infants Born in India: An RCT.Khurana, S., Rao, BK., Lewis, LE., et al.[2023]

References

Early physical therapy effects on the high-risk infant: a randomized controlled trial. [2007]
Early Parent-Administered Physical Therapy for Preterm Infants: A Randomized Controlled Trial. [2018]
Neonatal PT Improves Neurobehavior and General Movements in Moderate to Late Preterm Infants Born in India: An RCT. [2023]
The effects of an early physical therapy intervention for very preterm, very low birth weight infants: a randomized controlled clinical trial. [2019]
Effectiveness of developmental intervention in the neonatal intensive care unit: implications for neonatal physical therapy. [2019]
The effects of physical therapy on cerebral palsy. A controlled trial in infants with spastic diplegia. [2019]
Development of a quantitative tool to assess the content of physical therapy for infants. [2010]
Physical therapy for neonates with respiratory dysfunction. [2019]